A phase II trial of trastuzumab plus modified-FOLFOX for gemcitabine/cisplatin refractory HER2-positive biliary tract cancer (BTC): Multi-institutional study of the Korean Cancer Study Group (KCSG-HB19-14).
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Choong-Kun | - |
dc.contributor.author | Cheon, Jaekyung | - |
dc.contributor.author | Chon, Hong Jae | - |
dc.contributor.author | Kim, Min Hwan | - |
dc.contributor.author | Kim, Jin Won | - |
dc.contributor.author | Lee, Myung Ah | - |
dc.contributor.author | Park, Hyung Soon | - |
dc.contributor.author | Kang, Myoung Joo | - |
dc.contributor.author | Jang, Joung-Soon | - |
dc.contributor.author | Choi, Hye Jin | - |
dc.date.accessioned | 2022-01-26T02:43:07Z | - |
dc.date.available | 2022-01-26T02:43:07Z | - |
dc.date.issued | 2021-05 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.issn | 1527-7755 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/54517 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.title | A phase II trial of trastuzumab plus modified-FOLFOX for gemcitabine/cisplatin refractory HER2-positive biliary tract cancer (BTC): Multi-institutional study of the Korean Cancer Study Group (KCSG-HB19-14). | - |
dc.type | Article | - |
dc.identifier.doi | 10.1200/JCO.2021.39.15_suppl.TPS4161 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, v.39, no.15 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000708120306263 | - |
dc.citation.number | 15 | - |
dc.citation.title | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.citation.volume | 39 | - |
dc.type.docType | Meeting Abstract | - |
dc.publisher.location | 미국 | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.